Literature DB >> 19656736

Selective ganglionated plexi ablation for paroxysmal atrial fibrillation.

Evgeny Pokushalov1, Alex Romanov, Pavel Shugayev, Sergey Artyomenko, Natalya Shirokova, Alex Turov, Demosthenes G Katritsis.   

Abstract

BACKGROUND: Selective ganglionated plexi (GP) ablation guided by high-frequency stimulation has been proposed for the treatment of paroxysmal atrial fibrillation (AF), but the efficacy of the method is not established.
OBJECTIVE: This study sought to compare selective ablation of GP identified by high-frequency stimulation with extensive regional ablation targeting the anatomic areas of GP in patients with paroxysmal AF.
METHODS: Eighty patients with paroxysmal AF (age 53 +/- 9 years) were randomized to undergo selective GP ablation or regional left atrial ablation at the anatomic sites of GP. For selective GP ablation (n = 40), ablation targets were the sites where vagal reflexes were evoked by high-frequency stimulation. Vagal reflexes were defined as prolongation of the R-R interval by >50% and a concomitant decrease in blood pressure (>20 mm Hg) during AF. The end point of the procedure was failure to reproduce vagal reflexes with repeated high-frequency stimulation. For anatomic ablation, lesions were delivered at the sites of GP clustering.
RESULTS: At 13.1 +/- 1.9 months, 42.5% of patients with selective GP and 77.5% of patients with anatomic ablation were free of symptomatic paroxysmal AF (PAF) (P = .02). Parasympathetic denervation was more prominent in patients with anatomic than selective GP ablation, and in patients free of AF compared to these with AF recurrence immediately after ablation, but this trend was abolished at 6 months.
CONCLUSION: Selective GP ablation directed by high-frequency stimulation does not eliminate paroxysmal AF in the majority of patients. An anatomic approach for regional ablation at the sites of GP confers better results.

Entities:  

Mesh:

Year:  2009        PMID: 19656736     DOI: 10.1016/j.hrthm.2009.05.018

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  64 in total

1.  Ganglionated plexi ablation in right atrium to treat cardioinhibitory neurocardiogenic syncope.

Authors:  Marco Rebecchi; Ermenegildo de Ruvo; Stefano Strano; Luigi Sciarra; Paolo Golia; Annamaria Martino; Leonardo Calò
Journal:  J Interv Card Electrophysiol       Date:  2012-03-21       Impact factor: 1.900

Review 2.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

Review 3.  Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation.

Authors:  Christopher E Woods; Jeffrey Olgin
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 4.  Dysfunction of the autonomic nervous system in atrial fibrillation.

Authors:  Yutao Xi; Jie Cheng
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

Review 5.  Atrial Fibrillation in Athletes - The Story Behind The Running Hearts.

Authors:  Shaolong Li; Zhihui Zhang; Benjamin J Scherlag; Sunny S Po
Journal:  J Atr Fibrillation       Date:  2010-03-01

6.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

7.  Visualization and ablation of the autonomic nervous system corresponding to ganglionated plexi guided by D-SPECT 123I-mIBG imaging in patient with paroxysmal atrial fibrillation.

Authors:  Alexander Romanov; Stanislav Minin; Christopher Breault; Evgeny Pokushalov
Journal:  Clin Res Cardiol       Date:  2016-10-17       Impact factor: 5.460

8.  Novel Interventional Strategies for the Treatment of Atrial Fibrillation.

Authors:  Konstantinos C Siontis; Hakan Oral
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

9.  Intrinsic cardiac nerve activity and paroxysmal atrial tachyarrhythmia in ambulatory dogs.

Authors:  Eue-Keun Choi; Mark J Shen; Seongwook Han; Daehyeok Kim; Samuel Hwang; Sameh Sayfo; Gianfranco Piccirillo; Kyle Frick; Michael C Fishbein; Chun Hwang; Shien-Fong Lin; Peng-Sheng Chen
Journal:  Circulation       Date:  2010-06-07       Impact factor: 29.690

Review 10.  Neural mechanisms of atrial arrhythmias.

Authors:  Mark J Shen; Eue-Keun Choi; Alex Y Tan; Shien-Fong Lin; Michael C Fishbein; Lan S Chen; Peng-Sheng Chen
Journal:  Nat Rev Cardiol       Date:  2011-09-27       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.